Which is the best-performing stock index in the world? Most people would cite American indices like the Nasdaq 100 and S&P 500 as the best performers. Sure, these indices have done well over the years. However, the Nifty 50 index has been the best-performing index in the past few decades by far. Nifty 50 index… Continue reading Nifty 50 index vs S&P 500, Nasdaq 100: one clear winner in 2 decades
Stock Research
Li Auto stock price could dive by 20% if this happens
Li Auto (NASDAQ: LI) stock price has come under pressure in the past few days as concerns about the electric vehicle (EV) industry continued. The shares dropped to a low of $22.50, which was a few points below the year-to-date high of $$27.52. It remains about 85% above the lowest level in 2022, meaning it… Continue reading Li Auto stock price could dive by 20% if this happens
US pension system ranked 5th out of 75 countries
In recent personal finance news, Allianz Group, a global insurer and leading asset manager, released the Allianz Global Pension Report 2023, which ranked the world’s best pension systems as one of the best in the world. In the report, Denmark tops, the USA is ranked fifth while the top 10 includes Taiwan and New Zealand.… Continue reading US pension system ranked 5th out of 75 countries
Bed Bath & Beyond just filed for Chapter 11 bankruptcy
Bed Bath & Beyond Inc (NASDAQ: BBBY) just announced to have filed for Chapter 11 bankruptcy protection after none of its efforts in recent months raised capital needed to continue operations. Here’s what we know so far Sixth Street is lending roughly $240 million in “DIP” (debtor-in-possession financing) for the big box retailer to finance… Continue reading Bed Bath & Beyond just filed for Chapter 11 bankruptcy
BB Biotech reports a loss for the first three months of 2023
BB Biotech AG (SWX: BION) ended 3.0% down on Friday after reporting a loss for the first three months of 2023. BB Biotech’s loss narrowed year-on-year The investment firm that focuses exclusively on biotechnology says it lost CHF 254 million ($284.45 million) in the first quarter. In the same period last year, though, it had… Continue reading BB Biotech reports a loss for the first three months of 2023
Charles Schwab stock outlook: JPMorgan analyst sees 60% upside
U.S. banks have been under a lot of pressure lately but a JPMorgan analyst is still convinced that investing in Charles Schwab Corporation (NYSE: SCHW) at current levels positions you for lucrative returns. Charles Schwab stock could climb to $85 Kenneth Worthington reiterated the financial service company at “overweight” this week. His $85 price target… Continue reading Charles Schwab stock outlook: JPMorgan analyst sees 60% upside
BUD stock price: AB InBev preps for a new $27 billion move
AB Inbev (NYSE: BUD) stock has been in the spotlight this month as concerns about the company’s marketing remain. As I wrote here, the company has become disliked by both conservatives and liberals following its Dylan Mulvaney advertisements. In this article, I will explain why this controversy likely saved Anheuser-Busch. Boycotts never work Conservatives have… Continue reading BUD stock price: AB InBev preps for a new $27 billion move
Loandepot stock investors beware: insiders are dumping shares
Loandepot (NYSE: LDI) stock price has been in a strong sell-off in the past few months as concerns about the mortgage industry continue. The shares plunged from a high of $3 in February to a low of $1.38. It has now pulled back slightly to trade at $1.80. This performance is in line with other… Continue reading Loandepot stock investors beware: insiders are dumping shares
ContextLogic stock jumped 40% on Friday: here’s the catalyst
Shares of ContextLogic Inc (NASDAQ: WISH) went up as much as 40% today after the eCommerce company announced a share repurchase programme. How many shares will it buy back? On Friday, the Nasdaq-listed firm confirmed that it plans on buying back up to $50 million worth of its stock. The programme that will be effective… Continue reading ContextLogic stock jumped 40% on Friday: here’s the catalyst